Paediatric nephroblastoma at a South African tertiary hospital: A 21-year retrospective analysis
DOI:
https://doi.org/10.7196/SAMJ.2024.v114i12.2223Keywords:
Children, CancerAbstract
Background. Nephroblastoma (Wilms tumour) is one of the most common solid tumours of all paediatric cancers (prevalence of 5% globally and 13.5% in South Africa (SA)), with suboptimal survival outcomes, impacting children’s lives. Consequently, there is an urgent need for enhanced early detection strategies, addressing survival rate disparities and late-stage presentations to improve outcomes.
Objectives. To assess profiles, disease presentations, management and outcomes of patients with nephroblastoma at Universitas Academic Hospital Complex (UAHC), and to compare patients from SA and Lesotho, including differences between early and late presenters and reasons for delayed presentation.
Methods. This retrospective cross-sectional study included 207 paediatric oncology patients treated for nephroblastoma at the Paediatric Haematology and Oncology Unit at UAHC, Bloemfontein, SA, from January 2000 to December 2020.
Results. The median age of the study population was 38 months, with a marginal male predominance (50.7%). A 1-month delay occurred between symptom onset and diagnosis, commonly attributed to delayed care-seeking, impacting survival rates. Compared with similar SA studies, a higher stage IV disease rate (29.5%) was observed, and encouraging survival rates (59.4%) correlated with favourable preoperative histology and no relapse. In comparison, Lesotho patients experienced longer delays and presented with more severe disease.
Conclusion. This study highlights the need for collaboration between SA and Lesotho healthcare providers to improve outcomes by addressing diagnostic delays, treatment defaults and response variations in resource-limited settings through community health education, improving access to primary care, offering care-provider training, improving diagnostic resources and addressing socioeconomic barriers.
References
1. Popov SD, Sebire NJ, Vujanic GM. Wilms tumor – histology and differential diagnosis. In: Van den Heuvel-Eibrink MM, ed. Wilms’ Tumour. Singapore: Codon Publications, 2016. https:// exonpublications.com/index.php/exon/article/view/96/122 (accessed 11 April 2024).
2. Cunningham ME, Klug TD, Nuchtern JG, et al. Global disparities in Wilms tumor. J Surg Res 2020;247:34-51. https://doi.org/10.1016/j.jss.2019.10.044
3. World Health Organization. WHO Report on cancer: Setting priorities, investing wisely and providing care for all. Geneva: WHO, 2020. https://www.who.int/publications/i/item/9789240001299 (accessed 11 April 2024).
4. Stones DK, de Bruin GP, Esterhuizen TM, Stefan DC. Childhood cancer survival rates in two South African units. S Afr Med J 2014;104(7):501-504. https://doi.org/10.7196/SAMJ.7882
5. Stefan C, Bray F, Ferlay J, Liu B, Maxwell Parkin D. Cancer of childhood in sub-Saharan Africa. Ecancermedicalscience 2017;11:755. https://doi.org/10.3332/ecancer.2017.755
6. Stefan D. Epidemiology of childhood cancer and the SACCSG tumour registry. Contin Med Educ 2010;28(7);317-319. http://www.cmej.org.za/index.php/cmej/article/view/1837/1548 (accessed 11 April 2024). 7. Visser YT, Uys R, van Zyl A, Stefan DC. Nephroblastoma – a 25-year review of a South African unit. J Med Life 2014;7(3):445-449. https://scholar.sun.ac.za/items/9ebcdad5-e65f-48e6-bbe3-376b3e4aa54c
(accessed 11 April 2024).
8. Davidson A, Hartley P, Desai F, Daubenton J, Rode H, Millar A. Wilms tumour experience in a South
African centre. Pediatr Blood Cancer 2006;46(4):465-471. https://doi.org/10.1002/pbc.20388
9. Israels T, Pidini D, Borgstein E, et al. Survival of children with a Wilms tumor in Blantyre, Malawi.
Pediatr Hematol Oncol 2018;35(3):196-202. https://doi.org/10.1080/08880018.2018.1498564
10. Stones DK, Hadley GP, Wainwright RD, Stefan DC. The impact of ethnicity on Wilms tumor: Characteristics and outcome of a South African cohort. Int J Pediatr 2015:706058. https://doi.
org/10.1155/2015/706058
11. Paintsil V, David H, Kambugu J, et al. The Collaborative Wilms Tumour Africa Project; baseline evaluation of Wilms tumour treatment and outcome in eight institutes in sub-Saharan Africa. Eur J Cancer 2015;51(1):84-91. https://doi.org/10.1016/j.ejca.2014.10.030
12. Hadley LG, Rouma BS, Saad-Eldin Y. Challenge of pediatric oncology in Africa. Semin Pediatr Surg 2012;21(2):136-141. https://doi.org/10.1053/j.sempedsurg.2012.01.006
13. Howard SC, Zaidi A, Cao X, et al. The My Child Matters programme: Effect of public-private partnerships on paediatric cancer care in low-income and middle-income countries. Lancet Oncol 2018;19(5):e252-e266. https://doi.org/10.1016/S1470-2045(18)30123-2
14. Wilde JC, Lameris W, van Hasselt EH, Molyneux EM, Heij HA, Borgstein EG. Challenges and outcome of Wilms’ tumour management in a resource-constrained setting. Afr J Paediatr Surg 2010;7(3):159- 162. https://doi.org/10.4103/0189-6725.70416
15. Njuguna F, Martijn HA, Kuremu RT, et al. Wilms tumor treatment outcomes: Perspectives from a low- income setting. J Glob Oncol 2016;3(5):555-562. https://doi.org/10.1200/JGO.2016.005389
16. Kanyamuhunga A, Tuyisenge L, Stefan DC. Treating childhood cancer in Rwanda: the nephroblastoma example. Pan Afr Med J 2015;21:326. https://doi.org/10.11604/pamj.2015.21.326.5912
17. Atanda AT, Anyanwu LJ, Atanda OJ, Mohammad AM, Abdullahi LB, Farinyaro AU. Wilms’ tumour: Determinants of prognosis in an African setting. Afr J Paediatr Surg 2015;12(3):171-176. https://doi. org/10.4103/0189-6725.170185
18. Abdallah FK, Macharia WM. Clinical presentation and treatment outcome in children with nephroblastoma in Kenya. East Afr Med J 2001;78(7 Suppl):S43-47. https://ecommons.aku.edu/cgi/ viewcontent.cgi?article=1076&context=eastafrica_fhs_mc_paediatr_child_health (accessed 11 April 2024).
19. Stefan DC, Siemonsma F. Delay and causes of delay in the diagnosis of childhood cancer in Africa. Pediatr Blood Cancer 2011;56(1):80-85. https://doi.org/10.1002/pbc.22714
20. Brits E, le Grange SM. Biliary atresia: the profile, management and outcome of patients treated at a tertiary hospital in central South Africa. S Afr Med J 2023;113(11):57-26. https://doi.org/10.7196/ SAMJ.2023.v113i11.845
21. Arnold R, Khokho K, Narrainsamy K, Brits E, Joubert G. Infantile hypertrophic pyloric stenosis: profile, management and outcome of patients admitted to a tertiary hospital in Bloemfontein, South Africa. S Afr J Surg 2019;57(2):64. https://doi.org/10.17159/2078-5151/2019/v57n2a2811
22. Du Preez H, Brits E. The profile and outcome of small bowel atresia at Universitas Academic Hospital. S Afr J Surg 2023;61(1):61-65. https://doi.org/10.36303/SAJS.329
23. Brits E, le Grange. Perineal disintegration syndrome (PDS) in children with human immunodeficiency virus (HIV) infection: A scoping review. J Pediatr Surg 2024;59(11):161631. https://doi.org/10.1016/j. jpedsurg.2024.07.016
24. Abdelkhalek E, Sherief L, Kamal N, Soliman R. Factors associated with delayed cancer diagnosis in egyptian children. Clin Med Insights Pediatr 2014;8:39-44. https://doi.org/10.4137/CMPed.S16413 25. University of Rochester Medical Centre. Lactate dehydrogenase (blood). University of Rochester
Medical Centre , 2024. https://www.urmc.rochester.edu/encyclopedia/content.aspx?contenttypeid=1
67&contentid=lactic_acid_dehydrogenase_blood (accessed 24 April 2024).
26. Breslow N, Olshan A, Beckwith JB, Green DM. Epidemiology of Wilms tumor. Med Pediatr Oncol
1993;21(3):172-181. https://doi.org/10.1002/mpo.2950210305
27. Brok J, Lopez-Yurda M, Tinteren HV, et al. Relapse of Wilms’ tumour and detection methods:
A retrospective analysis of the 2001 Renal Tumour Study Group – International Society of Paediatric Oncology Wilms’ tumour protocol database. Lancet Oncol 2018;19(8):1072-1081. https://doi. org/10.1016/S1470-2045(18)30293-6
28. Chagaluka G, Paintsil V, Renner L, et al. Improvement of overall survival in the Collaborative Wilms Tumour Africa Project. Pediatr Blood Cancer 2020;67(9):e28383. https://doi.org/10.1002/pbc.28383
29. Nasir AA, Abdur-Raheem NT, Abdur-Rahman LO, et al. Characteristics and clinical outcomes of children with Wilms’ tumour: A 15-year experience in a single centre in Nigeria. J Pediatr Surg 2024;95(5):1009-1014. https://doi.org/10.1016/j.jpedsurg.2023.12.018
30. Wang J, Li M, Tang D, Gu W, Mao J, Shu Q. Current treatment for Wilms tumor: COG and SIOP standards. World J Pediatr Surg 2019;2(3):e000038. https://doi.org/10.1136/wjps-2019-000038
31. Statistics South Africa. Mid-year population estimates, 2019. Pretoria: Statistics South Africa, 2019. https://www.statssa.gov.za/publications/P0302/P03022019.pdf (accessed 11 April 2024).
32. Statistics South Africa (2013) Use of health facilities and levels of selected health conditions in South Africa: findings from the General Household Survey, 2011. Pretoria: Statistics South Africa. https:// www.statssa.gov.za/publications/Report-03-00-05/Report-03-00-052011.pdf. (accessed 11 April 2024).
33. Abera Abaerei A, Ncayiyana J, Levin J. Health-care utilization and associated factors in Gauteng province, South Africa. Glob Health Action 2017;10(1):1305765. https://doi.org/10.1080/16549716.2 017.130576534. Pritchard-Jones K, Graf N, van Tinteren H, Craft A. Evidence for a delay in diagnosis of Wilms’ tumour in the UK compared with Germany: implications for primary care for children. Arch Dis Child 2016;101(5):417-420. https://doi.org/10.1136/archdischild-2015-309212
35. Dome JS, Perlman EJ, Graf N. Risk stratification for Wilms tumor: Current approach and future directions. Am Soc Clin Oncol Educ Book 2014:215-223. https://doi.org/10.14694/EdBook_ AM.2014.34.215
36. Yao AJ, Moreira C, Traoré F, et al. Treatment of Wilms tumor in sub-Saharan Africa: Results of the Second French African Pediatric Oncology Group Study. J Glob Oncol 2019;5:1-8. https://doi. org/10.1200/JGO.18.00204
37. Friedrich P, Lam CG, Kaur G, Itriago E, Ribeiro RC, Arora RS. Determinants of treatment abandonment in childhood cancer: results from a global survey. PLoS ONE 2016;11(10):e0163090. https://doi.org/10.1371/journal.pone.0163090
38. Zekri W, Yacoub DM, Ibrahim A, Madney Y. Relapsed Wilms’ tumor in pediatric patients: Challenges in low- to middle-income countries-a single-center experience. J Egypt Natl Canc Inst 2020;32(1):21. https://doi.org/10.1186/s43046-020-00032-6
39. Reinhard H, Schmidt A, Furtwängler R, et al. Outcome of relapses of nephroblastoma in patients registered in the SIOP/GPOH trials and studies. Oncol Rep 2008;20(2):463-467. https://doi. org/10.3892/or_00000029
40. South African Children’s Cancer Study Group. South African Children’s Tumour Registry. SACCSG, 2024. http://saccsg.co.za/SACTRegistry (accessed 11 April 2024).
41. Cotterill SJ, Pearson AD, Pritchard J, et al. Clinical prognostic factors in 1277 patients with neuroblastoma: Results of the European Neuroblastoma Study Group ‘Survey’ 1982 - 1992. Eur J Cancer 2000;36(7):901-908. https://doi.org/10.1016/S0959-8049(00)00058-7
42. World Bank. Lesotho: Public health sector expenditure review. Washington, DC: World Bank Group, 2017. http://documents.worldbank.org/curated/en/311321517929746662/Lesotho-public-health-sector- expenditure-review (accessed 11 April 2024).
43. Draper KS, Hadley GP, Pillay K, Wiles NL. Relationship between nutritional status and treatment- related neutropenia in children with nephroblastoma. S Afr J Clin Nutr 2018;31(4):74-77. https://doi. org/10.1080/16070658.2017.1401289
Downloads
Published
Issue
Section
License
Copyright (c) 2024 E Brits, E Gerber, I Iroka, L Mgidlana, J Willoughby, S Dhlamini, P Nxumalo, S Sefadi, A Mthembu, J B Sempa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.
